Dec 14, 2017
In a recent study, researchers compared the efficacy of a direct oral anticoagulant agent with that of the standard-of-care treatment for cancer-associated venous thromboembolism.
Dec 14, 2017
According to three recent studies, which cancer type's survival trends are not impacted by racial disparities?
Dec 13, 2017
Treatment with venetoclax and rituximab significantly improved PFS among patients with relapsed or refractory CLL when compared with rituximab and chemotherapy.